Dyes and Pigments, published by Elsevier Science Ltd, stands as a pivotal journal in the field of chemical engineering, particularly focusing on the realms of dyes and pigments as materials with extensive application across industries. Since its inception in 1980, this journal has evolved to capture cutting-edge research until 2024, making significant contributions to both the Chemical Engineering and Process Chemistry and Technology domains, where it currently ranks in the Q2 category. With an impressive Scopus ranking placing it among the top 82nd percentile in General Chemical Engineering and the top 73rd percentile in Process Chemistry and Technology, it demonstrates a robust commitment to publishing high-quality, impactful research. Although it does not offer an open-access option, its comprehensive content remains accessible to a wide audience of researchers, professionals, and students who are deeply engaged in the study and development of new dye and pigment technologies. Engaging with this journal not only enriches knowledge but also facilitates critical discussions that drive future innovations in chemical material sciences.

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY is a prestigious academic journal published by Elsevier Science SA in the Netherlands, focusing on the interdisciplinary domains of photochemistry and photobiology. With a notable impact factor and distinguished recognition across multiple disciplines, including Q1 rankings in Biophysics, Radiation, and Radiological and Ultrasound Technology, this journal is at the forefront of research dissemination in its field. The publication spans over three decades, from 1987 to 2024, reflecting its long-standing commitment to advancing knowledge in areas critical to both fundamental and applied science. Researchers and professionals are encouraged to submit original research articles, reviews, and short communications that explore the interactions between light and biological systems, with the aim of fostering innovative solutions impacting health and technology. Although it operates on a subscription model, this journal remains a vital resource for all those engaged in the scientific exploration of these dynamic fields.

Optica Pura y Aplicada, published by the SOC ESPANOLA OPTICA, stands as a vital platform for the dissemination of cutting-edge research in the fields of Atomic and Molecular Physics, Optics, and related engineering disciplines. Established in Spain, this journal aims to foster the advancement of knowledge in optical science and technology by providing a rigorous peer-reviewed publication outlet for scholars, researchers, and practitioners. Despite being categorized in the Q4 quartile across multiple domains, including Engineering and Materials Science, the journal remains committed to contributing meaningful insights and advancements within its scope. With an ISSN of 0030-3917 and an E-ISSN of 2171-8814, the journal effectively reaches a global audience eager to explore innovative applications and theoretical developments in optics and materials science. Researchers and professionals alike will find in Optica Pura y Aplicada a valuable resource for enriching their understanding and practices in an ever-evolving field, fostering collaborations and promoting research growth until its converged conclusion in 2024.

Advances in Radiation Oncology, published by Elsevier Inc, is a premier international journal dedicated to the field of oncology and radiology, focusing on the latest groundbreaking research and innovations in radiation therapy. Launched as an Open Access journal in 2016, it has since carved out a significant niche in the academic community, featuring contributions that span a diverse range of topics including clinical practices, technologies, and outcomes in radiation oncology. With an impressive Q2 rankingOncology and Radiology, Nuclear Medicine and Imaging categories for 2023, and positioned within the 65th and 55th percentiles of Scopus ranks, it serves as an essential resource for researchers, medical professionals, and students alike. The journal not only emphasizes the importance of disseminating knowledge widely through its open access model but also aims to foster collaboration and innovation in the evolving landscape of cancer treatment. For those looking to stay at the forefront of radiotherapy research and advancements, Advances in Radiation Oncology is an invaluable platform for scholarly communication.

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.

International Journal of Radiation Oncology Biology Physics, published by Elsevier Science Inc, is a premier academic journal that has played a critical role in advancing the field of radiation oncology since its inception in 1975. With an impressive impact factor and recognition as a Q1 journal across multiple categories such as Cancer Research, Oncology, and Radiology, this journal serves as a vital resource for researchers, clinicians, and students dedicated to understanding and improving cancer treatment modalities. Its multifaceted scope encompasses original research, reviews, and innovative clinical studies, fostering a deeper understanding of the interplay between radiation, biology, and oncology. With a remarkable ranking in Scopus, including a top position in Radiation Physics and an elite percentile in Oncology, IJROBP remains at the forefront of scientific discovery and innovation in the management of cancer. A traditional subscription model ensures high-quality, peer-reviewed content, providing invaluable insights that continue to advance the standards of care and research in radiation oncology.

Blood Cancer Discovery is a premier academic journal published by the American Association for Cancer Research, dedicated to advancing the understanding of hematologic malignancies through cutting-edge research in the fields of oncology, biochemistry, and molecular biology. With an impressive impact factor and recognition as a Q1 journal across multiple disciplines, including cancer research and hematology, Blood Cancer Discovery serves as an essential platform for scholars and practitioners alike, facilitating impactful discourse and dissemination of pioneering findings. This open-access journal, established within the vibrant academic landscape of the United States, aims to bridge gaps in research and foster collaborations to ultimately enhance patient outcomes. Its Scopus rankings demonstrate its vital role in the critical advancement of cancer research and therapeutic development. By inviting contributions from a diverse range of disciplines, Blood Cancer Discovery is poised to drive innovation and inspire future advancements in understanding blood cancers.

Medical Gas Research is a prominent academic journal dedicated to the field of anesthesiology and pain medicine, published by Wolters Kluwer Medknow Publications. With an ISSN of 2045-9912, this journal operates under a robust open access model, facilitating the wide dissemination of research findings across a global audience. Based in India, Medical Gas Research aims to present innovative studies and reviews that explore the therapeutic applications of medical gases, their mechanisms of action, and their impact on various neurological conditions. The journal has an admirable positioning within academic rankings, holding a Q2 classification in Anesthesiology and Pain Medicine and a Q3 designation in Neuroscience (miscellaneous) for 2023, reflecting its significant influence in these domains. Moreover, it ranks #35 out of 136 in the field of Anesthesiology, highlighting its contribution to advancing this vital area of medicine. Overall, the journal serves as an essential resource for researchers, professionals, and students aiming to stay abreast of the latest advancements and interdisciplinary approaches within the medical gas research landscape.

Advanced Therapeutics, published by WILEY in the United Kingdom, stands at the forefront of medical and pharmaceutical research, offering invaluable insights from 2018 to 2024. This distinguished journal, with an E-ISSN of 2366-3987, is recognized for its exceptional academic rigor, boasting an impressive array of Q1 categorizations in essential fields such as Biochemistry (medical), Pharmaceutical Science, and Pharmacology. With its strategic focus on interdisciplinary studies and cutting-edge therapeutic developments, Advanced Therapeutics serves as a vital resource for researchers, professionals, and students keen on advancing their knowledge and contributing to the evolving landscape of medicine and genetics. The journal's high Scopus rankings further affirm its impact, with significant placements in multiple categories underscoring the quality of published research. Although the journal operates under a subscription model, its accessibility to high-impact findings ensures that it remains a pivotal platform for innovative discourse in therapeutics.

Welcome to the Journal of Innovative Optical Health Sciences, an esteemed platform dedicated to the interdisciplinary exploration of optical technologies in health sciences. Published by World Scientific Publishing Co Pte Ltd, this open-access journal has been at the forefront of innovation since its inception in 2008, facilitating vital discussions and research advancements. With a notable impact factor and a commendable ranking in various scientific categories—including Q2 in Atomic and Molecular Physics, Q3 in Biomedical Engineering, and Q3 in Medicine (miscellaneous)—the journal serves as an essential resource for researchers, professionals, and students alike. Hailing from Singapore, we aim to bridge the gap between optical science and healthcare, promoting breakthroughs that enhance patient care and medical practices. Explore our diverse collection of studies and join a vibrant community committed to advancing knowledge in this cutting-edge field.